Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
NMR Biomed ; 34(2): e4435, 2021 02.
Artículo en Inglés | MEDLINE | ID: mdl-33111456

RESUMEN

The goal of this study was to evaluate the accuracy, reproducibility, and efficiency of a 31 P magnetic resonance spectroscopic fingerprinting (31 P-MRSF) method for fast quantification of the forward rate constant of creatine kinase (CK) in mouse hindlimb. The 31 P-MRSF method acquired spectroscopic fingerprints using interleaved acquisition of phosphocreatine (PCr) and γATP with ramped flip angles and a saturation scheme sensitive to chemical exchange between PCr and γATP. Parameter estimation was performed by matching the acquired fingerprints to a dictionary of simulated fingerprints generated from the Bloch-McConnell model. The accuracy of 31 P-MRSF measurements was compared with the magnetization transfer (MT-MRS) method in mouse hindlimb at 9.4 T (n = 8). The reproducibility of 31 P-MRSF was also assessed by repeated measurements. Estimation of the CK rate constant using 31 P-MRSF (0.39 ± 0.03 s-1 ) showed a strong agreement with that using MT-MRS measurements (0.40 ± 0.05 s-1 ). Variations less than 10% were achieved with 2 min acquisition of 31 P-MRSF data. Application of the 31 P-MRSF method to mice subjected to an electrical stimulation protocol detected an increase in CK rate constant in response to stimulation-induced muscle contraction. These results demonstrated the potential of the 31 P-MRSF framework for rapid, accurate, and reproducible quantification of the chemical exchange rate of CK in vivo.


Asunto(s)
Forma MM de la Creatina-Quinasa/metabolismo , Miembro Posterior/diagnóstico por imagen , Proteínas Musculares/metabolismo , Resonancia Magnética Nuclear Biomolecular/métodos , Adenosina Trifosfato/metabolismo , Animales , Miembro Posterior/enzimología , Concentración de Iones de Hidrógeno , Cinética , Masculino , Ratones Endogámicos C57BL , Fósforo , Reproducibilidad de los Resultados
2.
Int Orthop ; 36(1): 199-205, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21567150

RESUMEN

PURPOSE: The present study was designed to address whether osteoblasts play a synergistic role in promoting mesenchymal stem cell (MSC) osteogenesis in a direct cell-cell contact co-culture model. METHODS: Murine C3H10T1/2 and MC3T3-E1 cell lines were mixed and plated onto 12-well culture plates and co-cultured at various ratios of initial cell densities. To compare the possible improvement on osteogenic differentiation, co-culture cells were served with or without osteogenic supplements in culture medium. RESULTS: Weak osteogenesis was induced in MSCs co-cultured in an untreated medium with different ratios of osteoblasts. An osteoblast-dependent increase in osteogenic gene expression of Runx2, type I collagen, and osteocalcin was observed over time. Moreover, both alkaline phosphatase (ALP) activity and calcium deposition were distinctly enhanced at levels that were proportional to the quantity of osteoblasts in the culture. The increases in mRNA expression and ALP activity were greater in co-cultures treated with osteogenic supplements than in untreated cultures. However, the production of ALP activity followed by a distinct matrix mineralization was lower in osteogenic-treated cultures containing greater numbers of osteoblasts. This suggests that a higher density of osteoblasts may lead to weak osteogenesis of MSCs by direct cell-cell contact co-culture in an untreated environment. Furthermore, additional osteogenic supplements may act synergistically with osteoblasts to accelerate matrix mineralization by reducing the process of osteogenic differentiation in osteogenic treated co-cultures. CONCLUSIONS: The present work may improve the understanding of MSC osteogenesis and may provide benefits for regenerative medicine.


Asunto(s)
Comunicación Celular/fisiología , Diferenciación Celular/fisiología , Células Madre Mesenquimatosas/citología , Osteoblastos/citología , Osteogénesis/fisiología , Células 3T3 , Fosfatasa Alcalina/metabolismo , Animales , Calcio/metabolismo , Técnicas de Cocultivo , Expresión Génica , Células Madre Mesenquimatosas/metabolismo , Ratones , Ratones Endogámicos C3H , Osteoblastos/metabolismo
3.
Int J Nanomedicine ; 6: 1365-71, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21760731

RESUMEN

BACKGROUND: San-Huang-Xie-Xin-Tang (SHXXT) decoction, a traditional Chinese medicine containing Rhei rhizome, Coptidis rhizome, and Scutellariae radix, is widely used in hepatoprotective therapy. However, preparation of the decoction requires addition of boiling water that causes loss of numerous effective components. METHODS: To improve the bioavailability of the decoction, nanoscale SHXXT was developed. Chloroform-induced liver injury and hepatic stellate cell activity in mice were used to demonstrate the hepatoprotective characteristics of nanoscale SHXXT decoction. RESULTS: Liver/body weight ratio and serum aspartate and alanine aminotranferase levels were recovered by the nanoscale SHXXT. TIMP-1 gene expression was inhibited and MMP-2 gene expression was accelerated in activated hepatic stellate cells. CONCLUSION: Nanoscale SHXXT decoction prepared in room temperature water could have preserved hepatoprotective ability. The results of this study indicate that nanoscale SHXXT could be extracted easily. The simple preparation of this herbal decoction is more convenient and energy-efficient.


Asunto(s)
Enfermedad Hepática Inducida por Sustancias y Drogas/tratamiento farmacológico , Medicamentos Herbarios Chinos/farmacología , Células Estrelladas Hepáticas/efectos de los fármacos , Nanopartículas/química , Sustancias Protectoras/farmacología , Animales , Peso Corporal/efectos de los fármacos , Cloroformo/efectos adversos , Sistemas de Liberación de Medicamentos , Medicamentos Herbarios Chinos/química , Femenino , Histocitoquímica , Hígado/efectos de los fármacos , Hígado/patología , Cirrosis Hepática/tratamiento farmacológico , Metaloproteinasa 2 de la Matriz/metabolismo , Ratones , Ratones Endogámicos ICR , Nanopartículas/ultraestructura , Nanotecnología , Tamaño de los Órganos/efectos de los fármacos , Tamaño de la Partícula , Sustancias Protectoras/química , Inhibidor Tisular de Metaloproteinasa-1/metabolismo
4.
Nanotechnology ; 20(37): 375102, 2009 Sep 16.
Artículo en Inglés | MEDLINE | ID: mdl-19706952

RESUMEN

Taking calcium supplements can reduce the risk of developing osteoporosis, but they are not readily absorbed in the gastrointestinal tract. Nanotechnology is expected to resolve this problem. In the present study, we examined whether the bioavailability of calcium carbonate and calcium citrate can be improved by reducing the particle size. The morphology of nano calcium carbonate and nano calcium citrate was characterized by dynamic laser-light scattering (DLS), field-emission scanning electron microscopy (FE-SEM) and transmission electron microscopy (TEM). The measurements obtained from DLS, FE-SEM and TEM were comparable. Acute and sub-chronic toxicity tests were performed to establish the safety of these products after oral administration. The no-observed-adverse-effect levels of nano calcium carbonate and nano calcium citrate were 1.3 and 2.3 g kg(-1) body weight, respectively. The results of our in vivo studies indicate that administering nano calcium carbonate and nano calcium citrate can enhance the serum calcium concentration and maintain the whole-body bone mineral density in ovariectomized mice. These data suggest that nano calcium carbonate and nano calcium citrate are more bioavailable than micro calcium carbonate and micro calcium citrate, respectively.


Asunto(s)
Conservadores de la Densidad Ósea/farmacología , Densidad Ósea/efectos de los fármacos , Carbonato de Calcio/farmacología , Citrato de Calcio/farmacología , Ovariectomía , Animales , Conservadores de la Densidad Ósea/efectos adversos , Calcio/sangre , Carbonato de Calcio/administración & dosificación , Carbonato de Calcio/efectos adversos , Citrato de Calcio/administración & dosificación , Citrato de Calcio/efectos adversos , Femenino , Masculino , Ratones , Ratones Endogámicos ICR , Microscopía Electrónica de Rastreo , Microscopía Electrónica de Transmisión , Nanopartículas/administración & dosificación , Nanopartículas/ultraestructura
5.
Curr Drug Metab ; 10(8): 905-13, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20214585

RESUMEN

A number of new nanotechnology-based Chinese herb drugs have been developed that have efficient biopharmaceutical properties and desirable target characteristics. This offers several alternatives for medical applications. Nanoparticles of Chinese herb drugs possess many benefits, such as improving component solubility, enhancement of bioavailability, increasing absorbency of the organism, reducing medicinal herb doses, and achieving steady-state therapeutic levels of drugs over an extended period compared with traditional Chinese herb drug preparations. There are two basic techniques, 'bottom up' or 'top down', to prepare Chinese herb nanoparticles. Furthermore, specific surface modifications and new design strategies of Chinese herb drug nanoparticles are created to profit clinical applications. This review presents recent advances in nanotechnology-based Chinese herb drugs.


Asunto(s)
Portadores de Fármacos/administración & dosificación , Medicamentos Herbarios Chinos/administración & dosificación , Nanopartículas/administración & dosificación , Nanotecnología/métodos , Animales , Portadores de Fármacos/química , Portadores de Fármacos/farmacocinética , Portadores de Fármacos/farmacología , Sistemas de Liberación de Medicamentos/métodos , Evaluación Preclínica de Medicamentos , Medicamentos Herbarios Chinos/química , Medicamentos Herbarios Chinos/farmacocinética , Medicamentos Herbarios Chinos/farmacología , Humanos , Estructura Molecular , Nanopartículas/química , Tamaño de la Partícula , Tecnología Farmacéutica/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA